Tejaswini Appidi Selected Research

1- palmitoyl- 2- docosahexaenoyl- sn- glycero- 3- phosphocholine (PDPC)

6/2022

A plasmon-enhanced fluorescent gold coated novel lipo-polymeric hybrid nanosystem: synthesis, characterization and application for imaging and photothermal therapy of breast cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tejaswini Appidi Research Topics

Disease

5	Neoplasms (Cancer) 06/2022 - 04/2018
2	Breast Neoplasms (Breast Cancer) 06/2022 - 12/2021
2	Skin Neoplasms (Skin Cancer) 09/2019 - 04/2018
1	Neoplasm Metastasis (Metastasis) 12/2021
1	Bacterial Infections (Bacterial Infection) 12/2021
1	Melanoma (Melanoma, Malignant) 09/2019
1	Acquired Immunodeficiency Syndrome (AIDS) 09/2019
1	Hyperthermia 09/2019

Drug/Important Bio-Agent (IBA)

2	GoldIBA 06/2022 - 09/2019
1	1- palmitoyl- 2- docosahexaenoyl- sn- glycero- 3- phosphocholine (PDPC)IBA 06/2022
1	Coloring Agents (Dyes)IBA 06/2022
1	Cadherins (E-Cadherin)IBA 12/2021
1	Virulence Factors (Pathogenicity Factors)IBA 12/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2020
1	CurcuminIBA 09/2019
1	Liposomes (Liposome)IBA 09/2019
1	Antineoplastic Agents (Antineoplastics)IBA 09/2019

Therapy/Procedure

3	Photothermal Therapy 06/2022 - 04/2018
2	Precision Medicine 01/2020 - 04/2018
1	Therapeutics 12/2021